TEVA 8229 TEVA 8229 Pill: yellow, capsule/oblong, 16mm
The pill with imprint TEVA 8229 TEVA 8229 (Yellow, Capsule/Oblong, 16mm) has been identified as Sunitinib Malate 37.5 mg and is used for Renal Cell Carcinoma, Gastrointestinal Stromal Tumor, and Pancreatic Cancer. It belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors and is not a controlled substance.
Images for TEVA 8229 TEVA 8229
Sunitinib Malate
- Imprint
- TEVA 8229 TEVA 8229
- Strength
- 37.5 mg
- Color
- Yellow
- Size
- 16.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors, VEGF/VEGFR inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA, Inc.
- National Drug Code (NDC)
- 00093-8229
- Inactive Ingredients
-
croscarmellose sodium,
magnesium stearate,
mannitol,
povidone k30,
gelatin,
titanium dioxide,
ferric oxide yellow,
ferrosoferric oxide,
D&C Yellow No. 10 Aluminium Lake,
FD&C Blue No. 1 Aluminium Lake,
FD&C Blue No. 2 Aluminium Lake,
FD&C Red No. 40,
shellac,
propylene glycol
Note: Inactive ingredients may vary.
See also:
More about sunitinib
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (35)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.